Latest News


The FH Foundation at NYU Langone Medical Center Advances in Cardiovascular Risk Reduction Symposium

FH Advocate for Awareness Colleen M. and Cat Davis Ahmed, Director of Outreach, hosted the FHF exhibit at NYU Langone Medical Center’s Cardiovascular Risk Reduction Symposium in New York City on May 8. Attendees included internists, family practitioners, cardiologists, general practice, endocrinologists, nurse … Read More


Changing the Lives of Patients with Familial Hypercholesterolemia

Geisinger Health System and the FH Foundation are partnering in a free web-based symposium on May 19-20 entitled “Changing the Lives of Patients with Familial Hypercholesterolemia”. We encourage patients, health care providers, and researchers to join us for this event.

To register:

For … Read More

Diane Davis

The FH Foundation at Grand Rounds – Hackensack University Medical Center – Hackensack, NJ

FH Advocate for Awareness, Diane Davis, joined FH Foundation Board Member Seth Baum, MD at Hackensack University Medical Center in NJ as part of our Grand Rounds Program to raise awareness of familial hypercholesterolemia in the medical community. With an audience of about 100 medical professionals, Dr. Baum gave his … Read More


To be an FH Advocate

Written By: Christian JacobsFH Advocate for Awareness and FH Foundation Board MemberAsk 20 people what a meaningful life looks like and you’ll probably get 20 different answers, but certain answers will make virtually everyone’s list.Most people would agree, for example, that a meaningful life includes something … Read More


June 9-10 – FDA’s Endocrinologic & Metabolic Drugs Advisory Committee Meeting

The Food and Drug Administration (FDA)’s Advisory Committee announced that it will review two applications for cholesterol lowering therapies known as PCSK9 inhibitors on June 9 and 10, 2015. This is a potentially exciting development for people with FH who have not been able to reach their cholesterol lowering … Read More